Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Death × Exercise × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Motor Activity 201 Breast Neoplasms 111 Neoplasms 88 Prostatic Neoplasms 33 Fatigue 28 Obesity 22 Colorectal Neoplasms 19 Lung Neoplasms 16 Colonic Neoplasms 15 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 10 Lymphedema 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Hematologic Neoplasms 8 Cardiotoxicity 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Cognitive Dysfunction 6 Brain Neoplasms 6 Overweight 5 Inflammation 5 Cachexia 5 Stomach Neoplasms 4

Interventions

Surveys and Questionnaires 3 Standard of Care 3 erythromycin propionate-N-acetylcysteinate 1 Therapeutics 1 Practice Guidelines as Topic 1 Palliative Care 1 Midazolam 1 Mass Screening 1 Interviews as Topic 1 Genes, p53 1 Focus Groups 1 Exercise 1 Diet 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03424668 2019-04-16

EPIC-Norfolk

University of Cambridge

Active not recruiting

25,639 enrolled

Cardiovascular Diseases, Death, Motor Activity, Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon ⚡